Icosagen and Lead Discovery Center Announce Collaboration to Discover Novel Monoclonal Antibodies

Icosagen announced a strategic partnership on selected projects with Lead Discovery Center GmbH. This alliance is focused on the discovery of monoclonal antibody portfolios targeting therapeutically relevant proteins, including a pivotal G-protein coupled receptor, which is often challenging to address.